VKH
NEOS

Virtu KCG Holdings’s Neos Therapeutics, Inc NEOS Stock Holding History

Virtu KCG Holdings’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$384K Buy
+52,619
New +$397K 0.01% 1400

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu KCG Holdings's NEOS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Neos Therapeutics, Inc (NEOS) in Q2 2017: 52,619 shares worth $384K. The stake represents 0.01% of the portfolio and ranks #1400 among its holdings.

67 funds tracked by Wall St. Rank hold NEOS as of Q2 2017.

  • Virtu KCG Holdings held 52,619 shares of Neos Therapeutics, Inc worth $384K as of Q2 2017.
  • Neos Therapeutics, Inc was a new Virtu KCG Holdings position in Q2 2017.
  • Neos Therapeutics, Inc made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1400 holding.
  • 67 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.